Subscribe to Newsletter

SeungSuh (Stanley) Hong

The Power List 2016

SeungSuh (Stanley) Hong

President and Chief Executive Officer, Celltrion Healthcare Co. Ltd

Stanley is both a scientist and a business man. He joined Celltrion in 2002 and is said to have made many contributions to the successful development of the company; he was also involved in the development of Remsima, the first biosimilar monoclonal antibody to be approved by the European Medicines Agency.

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine